Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-04-27

Clinical Trial Update: Vagus Nerve Stimulation to Augment Recovery From Minimally Conscious or Persistently Vegetative States After Traumatic Brain Injury [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial exploring vagus nerve stimulation to aid recovery after traumatic brain injury was withdrawn from Phase 2/Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vagus nerve stimulation (device/therapy)

Snippet

Sponsor: VA New York Harbor Healthcare System | Conditions: Minimally Conscious States Due to Traumatic Brain Injury, Persistently Vegetative States Due to Traumatic Brain Injury | Phase 2, Phase 3 | Status: WITHDRAWN